PubMed ID: 31038661 Author(s): Kaufman PL, Lütjen Drecoll E, Croft MA. Presbyopia and glaucoma: two diseases, one pathophysiology? The 2017 Friedenwald lecture. Invest Ophthalmol Vis Sci. 2019 Apr 1;60(5):1801-1812. doi: 10.1167/iovs.19-26899. Review. Erratum in: Invest …
Publications
Early Diagnosis and Management of Aggressive Posterior Vitreoretinopathy Presenting in Premature Neonates.
PubMed ID: 30998240 Author(s): Gupta MP, Yonekawa Y, Campbell JP, Rusu I, Zahid S, Patel SN, Chau F, Jonas KE, Oltra E, Orlin A, Chang J, Horowitz J, Abramson DH, Marr B, Capone A, Paul …
The impact of water molecules on binding affinity of the anti-diabetic thiazolidinediones for catalase: Kinetic and mechanistic approaches.
PubMed ID: 30738039 Author(s): Yekta R, Dehghan G, Rashtbari S, Sadeghi L, Baradaran B, Sheibani N, Moosavi-Movahedi AA. The impact of water molecules on binding affinity of the anti-diabetic thiazolidinediones for catalase: Kinetic and mechanistic …
Acquired Pediatric Brown Syndrome Secondary to Sinusitis.
PubMed ID: 30907972 Author(s): Lucarelli KM, Bradfield Y. Acquired pediatric brown syndrome secondary to sinusitis. J Pediatr Ophthalmol Strabismus. 2019 Mar 25;56:e17-e19. doi: 10.3928/01913913-20190213-01. PMID 30907972 Journal: Journal Of Pediatric Ophthalmology And Strabismus, Volume 56, …
Steered molecular dynamic simulations of conformational lock of Cu, Zn-superoxide dismutase.
PubMed ID: 30867507 Author(s): Xiao BL, Ning YN, Niu NN, Li D, Moosavi-Movahedi AA, Sheibani N, Hong J. Steered molecular dynamic simulations of conformational lock of Cu, Zn-superoxide dismutase. Sci Rep. 2019 Mar 13;9(1):4353. doi: …
Month 12 Outcomes After Treatment Change at Month 6 Among Poor Responders to Aflibercept or Bevacizumab in Eyes With Macular Edema Secondary to Central or Hemiretinal Vein Occlusion: A Secondary Analysis of the SCORE2 Study.
PubMed ID: 30589922 Author(s): Ip MS, Oden NL, Scott IU, VanVeldhuisen PC, Blodi BA, Ghuman T, Baker CW; SCORE2 Investigator Group. Month 12 outcomes after treatment change at month 6 among poor responders to aflibercept …
Progressive Proptosis and Worsening Vision.
PubMed ID: 30570651 Author(s): Lucarelli KM, Raven ML, Lucarelli MJ. Progressive proptosis and worsening vision. JAMA Ophthalmol. 2019 Mar 1;137(3):312-313. doi: 10.1001/jamaophthalmol.2018.5024. PMID 30570651 Journal: Jama Ophthalmology, Volume 137, Issue 3, Mar 2019
Simultaneous assessment of aberrant retinal vascularization, thickness, and function in an in vivo mouse oxygen-induced retinopathy model.
PubMed ID: 30209267 Author(s): Mezu-Ndubuisi OJ, Adams T, Taylor LK, Nwaba A, Eickhoff J. Simultaneous assessment of aberrant retinal vascularization, thickness, and function in an in vivo mouse oxygen-induced retinopathy model. Eye (Lond). 2019 Mar;33(3):363-373. …
Intravitreal Delivery of VEGF-A165-loaded PLGA Microparticles Reduces Retinal Vaso-Obliteration in an In Vivo Mouse Model of Retinopathy of Prematurity.
PubMed ID: 30383455 Author(s): Mezu-Ndubuisi OJ, Wang Y, Schoephoerster J, Falero-Perez J, Zaitoun IS, Sheibani N, Gong S. Intravitreal delivery of VEGF-A(165)-loaded PLGA microparticles reduces retinal vaso-obliteration in an in vivo mouse model of retinopathy …